Lymphoproliferative disorders News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Atara Biotherapeutics Announces Updated Positive Interim Results from Multicenter Expanded Access Study of ... - GlobeNewswire (press release)



Atara Biotherapeutics Announces Updated Positive Interim Results from Multicenter Expanded Access Study of ... 
GlobeNewswire (press release)
Since its discovery as the first human oncovirus, Epstein-Barr virus (EBV) has been implicated in the development of a wide range of lymphoproliferative disorders, including lymphomas and other cancers. EBV is widespread in all human populations and ...

and more » 


Bellicum Pharma (BLCM) Reports Data Presentation Demonstrating Improved Immune Recovery Following ... - StreetInsider.com



Bellicum Pharma (BLCM) Reports Data Presentation Demonstrating Improved Immune Recovery Following ... 
StreetInsider.com
Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) today announced results from a leading European transplant center participating in the BP-004 trial in children with blood cancers and nonmalignant disorders. Patients were treated with BPX-501 following an ...

 


Mogamulizumab: Valuable New Option for Cutaneous Lymphoma - Medscape



Medscape
 
Mogamulizumab: Valuable New Option for Cutaneous Lymphoma 
Medscape
CTCL is a group of lymphoproliferative disorders characterized by localization of neoplastic T lymphocytes to the skin; collectively, CTCL is classified as a type of non-Hodgkin lymphoma. "We don't think a lot about CTCL because it is one of the rare ...

 


Bellicum Announces Data Presentation Demonstrating Improved Immune Recovery Following Haploidentical Stem ... - GlobeNewswire (press release)



Bellicum Announces Data Presentation Demonstrating Improved Immune Recovery Following Haploidentical Stem ... 
GlobeNewswire (press release)
ATLANTA, Dec. 09, 2017 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, today announced results from a leading ...

and more » 


Hematopoietic Stem Cell Transplantation Market: Segmental Highlights and Table of Content (2025)7) - satPRnews (press release)



Hematopoietic Stem Cell Transplantation Market: Segmental Highlights and Table of Content (2025)7) 
satPRnews (press release)
The study presented here is based on a report by Transparency Market Research (TMR), titled ?Hematopoietic Stem Cell Transplantation (HSCT) Market (Transplant Type ? Allogeneic (Family Related and Unrelated) and Autologous; Disease Indication ...

and more » 


Program Aims to Raise Awareness of Lupus Among Blacks - Afro American



Afro American
 
Program Aims to Raise Awareness of Lupus Among Blacks 
Afro American
?Lupus can be difficult to diagnose because many of the signs and symptoms are similar to other diseases, can be interpreted as connective-tissue diseases, like rheumatoid arthritis, lymphoproliferative disorders, and chronic infections like HIV ...

 


Hematopoietic Stem Cell Transplantation Market Is Projected to Bring in US$37.61 Bn by 2025 - Life Pulse Health



Hematopoietic Stem Cell Transplantation Market Is Projected to Bring in US$37.61 Bn by 2025 
Life Pulse Health
The study presented here is based on a report by Transparency Market Research (TMR), titled ?Hematopoietic Stem Cell Transplantation (HSCT) Market (Transplant Type ? Allogeneic (Family Related and Unrelated) and Autologous; Disease Indication ...

and more » 


A Rare Case of Classical Hodgkin Lymphoma 10 Years After Liver Transplantation - Oncology Nurse Advisor



Oncology Nurse Advisor
 
A Rare Case of Classical Hodgkin Lymphoma 10 Years After Liver Transplantation 
Oncology Nurse Advisor
Posttransplant lymphoproliferative disorders (PTLDs) are rare and potentially life-threatening complications that may arise from solid organ transplantation or allogeneic hematopoietic stem cell transplantation. PTLD risk is associated with Epstein ...

 


Hematopoietic Stem Cell Transplantation Market to Witness Robust Expansion by 2025 - NB Herard



Hematopoietic Stem Cell Transplantation Market to Witness Robust Expansion by 2025 
NB Herard
Depending on type of disease indication, the report has segmented the global HSCT market into lymphoproliferative disorders, leukemia, and non-malignant disorders. Lymphoproliferative disorders have surfaced as the leading segment of this market and is ...

and more » 


Global Hematopoietic Stem Cell Transplantation (HSCT) Market to Reach a Value of US $37.61 Bn During 2016-2024 - NB Herard



Global Hematopoietic Stem Cell Transplantation (HSCT) Market to Reach a Value of US $37.61 Bn During 2016-2024 
NB Herard
The global hematopoietic stem cell transplantation (HSCT) market is divided into: by transplant type, by disease indication, by application and by geography. Transplant type segment of HSCT market was divided into autologous transplant and allogeneic ...

and more »